Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: Effects of viral diversity, target cell and receptor density
- 30 November 2005
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 68 (2) , 96-108
- https://doi.org/10.1016/j.antiviral.2005.07.006
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency VirusJournal of Virology, 2005
- Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 InhibitorJournal of Virology, 2004
- Long-Term Treatment with Subcutaneous T-20, a Fusion Inhibitor, in HIV-Infected Patients: Patient Satisfaction and Impact on Activities of Daily LivingAIDS Patient Care and STDs, 2002
- Establishment of a New System for Determination of Coreceptor Usages of HIV Based on the Human Glioma NP-2 Cell LineBiochemical and Biophysical Research Communications, 1999
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- HIV coreceptors, cell tropism and inhibition by chemokine receptor ligandsMolecular Membrane Biology, 1999
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984